Target and method for inhibition of bacterial RNA polymerase
View Patent ↗Target and method for inhibition of bacterial RNA polymerase disclosed are targets and methods for specific binding and inhibition of RNAP from bacterial species.
1. A method for identifying an agent that binds to a homologous secondary channel amino acid sequence of a bacterial RNA polymerase (RNAP) in a first entity, comprising the steps of: (a) preparing a reaction solution including the agent to be tested and a first entity including a homologous secondary channel amino acid sequence of a bacterial RNAP; and (b) detecting at least one of the presence, extent, concentration-dependence, or kinetics of binding of the agent to the homologous secondary channel amino acid sequence, wherein the agent is not MccJ25.
2. The method of claim 1 wherein the first entity is an intact bacterial RNAP.
3. The method of claim 1 wherein the first entity is Escherichia coli RNAP or Bacillus subtilis RNAP.
4. The method of claim 1 further comprising comparison of: (a) the binding of the agent to the first entity; and (b) the binding of the agent to a second entity that contains a derivative of a bacterial RNAP homologous secondary channel amino acid sequence having at least one substitution, insertion, or deletion.
5. The method of claim 4 wherein the second entity is a derivative of an intact bacterial RNAP.
6. The method of claim 4 wherein the second entity is a Escherichia coli RNAP or Bacillus subtilis RNAP.
7. The method of claim 4 further comprising comparison of: (a) at least one of the presence, extent, concentration-dependence, or kinetics of binding of the agent to the first entity; and (b) at least one of the presence, extent, concentration-dependence, or kinetics of binding of the agent to a eukaryotic RNAP.
8. The method of claim 7 wherein the eukaryotic RNAP is selected from the group consisting of human RNAP and human RNAP II.
9. The method of claim 7 further comprising comparison of: (a) at least one of the presence, extent, concentration-dependence, or kinetics of binding of the agent to the first entity; and (b) at least one of the presence, extent, concentration-dependence, or kinetics of binding of MccJ25 to the first entity.
10. A method for identifying an agent that inhibits an activity of a bacterial RNAP by binding to a homologous secondary channel amino acid sequence of a bacterial RNAP, comprising: (a) preparing a reaction solution comprising the agent to be tested and a first entity containing a homologous secondary channel amino acid sequence of a bacterial RNAP; and (b) detecting the at least one of the presence, extent, concentration-dependence, or kinetics of inhibition of an activity of said first entity, wherein inhibition involves binding of the agent to the homologous secondary channel amino acid sequence, wherein the agent is not MccJ25.
11. The method of claim 10 wherein the first entity is an intact bacterial RNAP.
12. The method of claim 10 wherein the first entity is Escherichia coli RNAP or Bacillus subtilis RNAP.
13. The method of claim 10 wherein the activity is selected from the group consisting of RNA synthesis, NTP uptake, pyrophosphate release, abortive-RNA release, edited-RNA release, transcriptional pausing transcriptional arrest, and Gre-factor binding.
14. The method of claim 10 further comprising comparison of: (a) at least one of the presence, extent, concentration-dependence, or kinetics of the inhibition by the agent of an activity of the first entity; and (b) at least one of the presence, extent, concentration-dependence, or kinetics of the inhibition by the agent of an activity of a second entity that contains a derivative of a bacterial RNAP homologous secondary channel amino acid having at least one substitution, insertion, or deletion.